Asymchem Laboratories (Tianjin) Management
Management criteria checks 2/4
Asymchem Laboratories (Tianjin)'s CEO is Hao Hong, appointed in Jan 2022, has a tenure of 2.83 years. directly owns 4.02% of the company’s shares, worth CN¥1.23B. The average tenure of the management team and the board of directors is 2.8 years and 13.3 years respectively.
Key information
Hao Hong
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.8yrs |
| CEO ownership | 4.0% |
| Management average tenure | 2.8yrs |
| Board average tenure | 13.3yrs |
Recent management updates
Recent updates
Earnings Troubles May Signal Larger Issues for Asymchem Laboratories (Tianjin) (SZSE:002821) Shareholders
Nov 05
Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)
Oct 15Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump
Sep 28Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation?
Jul 16Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80
Jun 27Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price
Jun 26Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet?
May 22Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next
Apr 03Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term
Apr 02A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)
Mar 26Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | CN¥769m |
| Jun 30 2024 | n/a | n/a | CN¥1b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | n/a | n/a | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥3b |
| Jun 30 2023 | n/a | n/a | CN¥3b |
| Mar 31 2023 | n/a | n/a | CN¥3b |
| Jan 01 2023 | n/a | n/a | CN¥3b |
| Sep 30 2022 | n/a | n/a | CN¥3b |
| Jun 30 2022 | n/a | n/a | CN¥2b |
| Mar 31 2022 | n/a | n/a | CN¥1b |
| Dec 31 2021 | CN¥2m | CN¥2m | CN¥1b |
| Sep 30 2021 | n/a | n/a | CN¥908m |
| Jun 30 2021 | n/a | n/a | CN¥830m |
| Mar 31 2021 | n/a | n/a | CN¥766m |
| Dec 31 2020 | CN¥2m | CN¥2m | CN¥719m |
| Sep 30 2020 | n/a | n/a | CN¥694m |
| Jun 30 2020 | n/a | n/a | CN¥640m |
| Mar 31 2020 | n/a | n/a | CN¥570m |
| Dec 31 2019 | CN¥2m | n/a | CN¥554m |
Compensation vs Market: Insufficient data to establish whether Hao's total compensation is reasonable compared to companies of similar size in the CN market.
Compensation vs Earnings: Hao's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Hao Hong (68 yo)
2.8yrs
Tenure
CN¥9,152,000
Compensation
Dr. Hao Hong, Ph D serves as the Chief Executive Officer of Asymchem Life Science (Tianjin) Co. Ltd. Dr. Hong serves as Chairman, Chief Executive Officer and President of Asymchem Laboratories, Inc. Dr. Ho...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 2.8yrs | CN¥9.15m | 4.02% CN¥ 1.2b | |
| Co-CEO & Executive Director | 2.8yrs | CN¥6.64m | no data | |
| CFO, Senior VP & Executive Director | 6.3yrs | CN¥5.88m | 0.071% CN¥ 20.8m | |
| Executive VP & Executive Director | 2.8yrs | CN¥3.54m | 0.0056% CN¥ 1.7m | |
| CTO & CBO | 1.8yrs | no data | no data | |
| Chief Scientific Officer | 2.8yrs | CN¥2.29m | no data | |
| Executive Vice President | 2.8yrs | CN¥665.70k | 0.025% CN¥ 7.5m | |
| Senior Vice President of Business Development | no data | no data | no data | |
| Senior Vice President of Process Development | no data | CN¥1.58m | no data | |
| Senior Vice President of 5S Management | no data | no data | no data | |
| Executive Vice President | 2.8yrs | no data | 0.071% CN¥ 20.9m | |
| Senior Vice President of Process Development & Application | 6.8yrs | no data | no data |
2.8yrs
Average Tenure
48.5yo
Average Age
Experienced Management: 002821's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 13.3yrs | CN¥9.15m | 4.02% CN¥ 1.2b | |
| Co-CEO & Executive Director | 13.3yrs | CN¥6.64m | no data | |
| CFO, Senior VP & Executive Director | 5.6yrs | CN¥5.88m | 0.071% CN¥ 20.8m | |
| Executive VP & Executive Director | 13.3yrs | CN¥3.54m | 0.0056% CN¥ 1.7m | |
| Non-Executive Director | 13.3yrs | CN¥752.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non Executive Director | 3.4yrs | CN¥128.00k | no data | |
| Chairman of the Supervisory Committee | 13.3yrs | no data | no data | |
| Non-Executive Director | 3.8yrs | CN¥1.93m | 0.00087% CN¥ 255.9k | |
| Member of Scientific Advisory Board | no data | no data | no data |
13.3yrs
Average Tenure
46yo
Average Age
Experienced Board: 002821's board of directors are seasoned and experienced ( 13.3 years average tenure).